Relationship between ecstasy use and depression: a study controlling for poly-drug use

Area of Science:

• Neuroscience
• Psychiatry
• Psychology

Background:

• 3,4-Methylenedioxymethamphetamine (MDMA) is known to damage serotonin neurons in animals, impacting mood regulation.
• Previous studies link MDMA use to higher depression scores, but often fail to control for concurrent poly-drug use.
• Serotonin system dysfunction is implicated in mood disorders.

Purpose of the Study:

• To investigate the association between MDMA use and affective disturbance.
• To rigorously control for poly-drug use when examining MDMA's effects on mood.
• To differentiate MDMA's specific impact from general illicit substance use.

Main Methods:

• Study included current MDMA users, poly-drug users (no MDMA), drug-naïve controls, and ex-MDMA users.
• Groups were matched for non-MDMA drug use to isolate MDMA's effects.
• Beck Depression Inventory (BDI) and Affective Go/No-go task were used to assess depression and affective bias.

Main Results:

• Current and ex-MDMA users reported significantly higher depression scores (BDI) than drug-naïve controls.
• No significant difference in BDI scores was found between MDMA users and poly-drug controls.
• No group differences emerged in affective bias as measured by the Affective Go/No-go task.

Conclusions:

• Elevated self-reported depression in MDMA users is not exclusively attributable to MDMA itself.
• MDMA users do not exhibit the same attentional biases towards negative stimuli seen in clinically depressed individuals.
• Findings suggest the need to consider poly-drug use when assessing mood disturbances in MDMA users.